Xiaozhou He

1.6k total citations
47 papers, 1.2k citations indexed

About

Xiaozhou He is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xiaozhou He has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 30 papers in Cancer Research and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xiaozhou He's work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (17 papers). Xiaozhou He is often cited by papers focused on MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (17 papers). Xiaozhou He collaborates with scholars based in China, United States and Italy. Xiaozhou He's co-authors include Ying Xia, Yilin Yang, Dongman Chao, Lawrence H. Lazarus, Yuan Feng, Renfang Xu, Xianlin Xu, Donglin Sun, Cui Li and Dong Xue and has published in prestigious journals such as PLoS ONE, Brain Research and Cellular and Molecular Life Sciences.

In The Last Decade

Xiaozhou He

46 papers receiving 1.2k citations

Peers

Xiaozhou He
Jian‐peng Teoh United States
Ning Bai China
Daniela Pretti da Cunha Tirapelli Brazil
Hirofumi Miyazaki Japan
Haikang Zhao China
Lisa Young United States
Hailin Liu China
Wei‐Bing Xie China
Jian‐peng Teoh United States
Xiaozhou He
Citations per year, relative to Xiaozhou He Xiaozhou He (= 1×) peers Jian‐peng Teoh

Countries citing papers authored by Xiaozhou He

Since Specialization
Citations

This map shows the geographic impact of Xiaozhou He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhou He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhou He more than expected).

Fields of papers citing papers by Xiaozhou He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhou He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhou He. The network helps show where Xiaozhou He may publish in the future.

Co-authorship network of co-authors of Xiaozhou He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhou He. A scholar is included among the top collaborators of Xiaozhou He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhou He. Xiaozhou He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shuang, Guannan Shu, Minyu Chen, et al.. (2025). STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis. Cell Death and Disease. 16(1). 125–125. 4 indexed citations
2.
3.
Shen, Zhiyong, Dong Xue, Kun Wang, et al.. (2022). Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway. BMC Urology. 22(1). 79–79. 15 indexed citations
4.
Liang, Bin, Cuixing Zhou, Hao Lu, et al.. (2021). Upregulation of miR-18a-5p promotes the proliferation of prostate cancer via inhibiting the expression of SLC40A1. Pathology - Research and Practice. 224. 153448–153448. 17 indexed citations
5.
Zhuang, Qianfeng, Jie Shen, Zhen Chen, et al.. (2021). MiRNA-124 regulates the sensitivity of renal cancer cells to cisplatin-induced necroptosis by targeting the CAPN4-CNOT3 axis. Translational Andrology and Urology. 10(9). 3669–3683. 11 indexed citations
6.
Chen, Yimeng, Xiaozhou He, Shu‐Ming Wang, & Ying Xia. (2020). δ-Opioid Receptors, microRNAs, and Neuroinflammation in Cerebral Ischemia/Hypoxia. Frontiers in Immunology. 11. 421–421. 29 indexed citations
7.
Miao, Liying, et al.. (2019). LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14. Journal of Experimental & Clinical Cancer Research. 38(1). 143–143. 48 indexed citations
8.
Shu, Yan, et al.. (2019). <p>miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer</p>. OncoTargets and Therapy. Volume 12. 3595–3607. 15 indexed citations
9.
Xing, Zhaoyu, et al.. (2018). Bromodomain-Containing Protein 4 (BRD4) Inhibition Sensitizes Palomid 529-Induced Anti-Renal Cell Carcinoma Cell Activity in Vitro and in Vivo. Cellular Physiology and Biochemistry. 50(2). 640–653. 9 indexed citations
10.
Zhuang, Qianfeng, Weiping Luo, Mingran Zhang, et al.. (2018). Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin&ndash;focal adhesion kinase signaling pathway. Acta Biochimica et Biophysica Sinica. 50(5). 465–472. 8 indexed citations
11.
Shen, Jie, Qianfeng Zhuang, Zhen Chen, et al.. (2017). Capn4 induces human renal cancer cell proliferation by activating NF-κB signaling pathway through FAK phosphorylation.. PubMed Central. 10(7). 7466–7474. 2 indexed citations
12.
Yang, Hongqiong, Wei Xia, Cui Li, et al.. (2017). Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2. Life Sciences. 190. 7–14. 24 indexed citations
13.
Yang, Min, Bin Wang, Liying Miao, Xianlin Xu, & Xiaozhou He. (2016). Autophagy is involved in aldosterone-induced mesangial cell proliferation. Molecular Medicine Reports. 14(5). 4638–4642. 5 indexed citations
14.
Shi, Qianqian, et al.. (2015). MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma. Oncology Letters. 11(2). 1474–1480. 26 indexed citations
15.
Xu, Haiyan, et al.. (2013). Involvement of miR-338-5p in antibody-mediated renal allograft rejection by targeting TRAF3. 34(9). 554–558. 1 indexed citations
16.
He, Xiaozhou, Yilin Yang, Feng Zhi, et al.. (2013). δ-Opioid Receptor Activation Modified MicroRNA Expression in the Rat Kidney under Prolonged Hypoxia. PLoS ONE. 8(4). e61080–e61080. 15 indexed citations
17.
Yang, Yilin, Feng Zhi, Xiaozhou He, et al.. (2012). δ-Opioid Receptor Activation and MicroRNA Expression of the Rat Cortex in Hypoxia. PLoS ONE. 7(12). e51524–e51524. 15 indexed citations
18.
Li, Cui, Hua Zhou, Hu Zhao, et al.. (2012). MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. BMC Cancer. 12(1). 546–546. 84 indexed citations
19.
He, Xiaozhou, Harleen K. Sandhu, Yilin Yang, et al.. (2012). Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events. Cellular and Molecular Life Sciences. 70(13). 2291–2303. 67 indexed citations
20.
Qian, Hong, Yuan Feng, Xiaozhou He, et al.. (2011). Effects of inhibitory amino acids on expression of GABAA Rα and glycine Rα1 in hypoxic rat cortical neurons during development. Brain Research. 1425. 1–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian‐peng Teoh Breakdown of academic impact, for papers by Ning Bai Breakdown of academic impact, for papers by Daniela Pretti da Cunha Tirapelli Breakdown of academic impact, for papers by Hirofumi Miyazaki Breakdown of academic impact, for papers by Haikang Zhao Breakdown of academic impact, for papers by Lisa Young Breakdown of academic impact, for papers by Hailin Liu Breakdown of academic impact, for papers by Wei‐Bing Xie
Rankless by CCL
2026